Construction of a STIM1 score (derived from non-malignant cells) in bulky melanoma tissues with available clinical data allowed us to examine the correlation between patient survival and STIM1-mediated cellular programs from non-malignant cell types (Figure 5A). Here, STIM1 is linked to melanoma.